Seigo Katakura

Yokohama, 2418515, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Comparison of Amplicon-Based Next-Generation Sequencing Testing and Immunohistochemical Staining in Detecting Anaplastic Lymphoma Kinase Fusion Genes in Non-Small-Cell Lung Cancer: A Large Single-Centre Cohort Study.

Comparison of Amplicon-Based Next-Generation Sequencing Testing and Immunohistochemical Staining in Detecting Anaplastic Lymphoma Kinase Fusion Genes in Non-Small-Cell Lung Cancer: A Large Single-Centre Cohort Study.

Journal: Cancers

Published: June 03, 2026

Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report.

Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report.

Journal: Respiratory investigation

Published: February 01, 2026

Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

Journal: Thoracic cancer

Published: September 22, 2025

Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block.

Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block.

Journal: Japanese journal of clinical oncology

Published: September 04, 2025

Impact of Phrenic Nerve Repair Using Intercostal Nerve Graft on Diaphragm Function after Thoracic Tumour Resection.

Impact of Phrenic Nerve Repair Using Intercostal Nerve Graft on Diaphragm Function after Thoracic Tumour Resection.

Journal: Interdisciplinary cardiovascular and thoracic surgery

Published: August 31, 2025

The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.

The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.

Journal: Genes

Published: August 22, 2025

Cemiplimab in Japanese patients with advanced non-small cell lung cancer.

Cemiplimab in Japanese patients with advanced non-small cell lung cancer.

Journal: Japanese journal of clinical oncology

Published: July 11, 2025

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Translational lung cancer research

Published: January 30, 2025

The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids.

The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids.

Journal: Genes

Published: August 29, 2024

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.

Journal: JAMA oncology

Published: March 07, 2024

Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis.

Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis.

Journal: Cancer medicine

Published: November 11, 2023

Clinically-meaningful improvements in therapy for unresectable NSCLC.

Clinically-meaningful improvements in therapy for unresectable NSCLC.

Journal: Expert review of anticancer therapy

Published: July 15, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026